EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Sustainment of Tobacco Use Treatment Programs Across National Cancer Institute–Designated Cancer Centers

Ramzi G Salloum iD, Magda Montague iD, Mara Minion, Jennifer H LeLaurin, Ji-Hyun Lee, Edmond Ramly, Gonghao Liu, Miranda Reid, Carma L Bylund iD, Danielle McCarthy, Donna Shelley, Jamie S Ostroff und 1 weitere

Cancer Medicine · 2025-11 · 14 (22)

DOI: 10.1002/cam4.71424 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Medicine, online erschienen am 26.11.2025. Verfasst von Ramzi G Salloum und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Florida College of Medicine, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Tobacco Use Cessation, Tobacco Use, Cancer Care Facilities, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Though tobacco use treatment (TUT) after a cancer diagnosis can improve cancer treatment outcomes and survival, delivery of evidence‐based TUT remains underutilized in cancer care. The National Cancer Institute (NCI) Cancer Center Cessation Initiative (C3I) implemented TUT across 52 NCI‐Designated Cancer Centers, but there is little information on its long‐term sustainment. This study assesses TUT sustainment beyond initial implementation in C3I.

Methods

A web‐based survey across 52 C3I centers was conducted during the sustainment phase (2023–2024) following NCI C3I funding. The surveys assessed program funding and the sustainment of the overall program, program components and practices, assessment of implementation and patient outcomes, partnerships, and program scale‐out across settings. The survey data were analyzed using descriptive statistics.

Results

Among 47 responding sites (90% response rate), 83% reported continued TUT activity after NCI funding ended with annual operating budgets between $100,000 and $250,000. Most sites (78.7%) reported some institutional support, while few relied on fee‐for‐service reimbursement (27.7%), bundled payments (8.1%), or support from grants (27.7%) and philanthropic donations (21.3%). Key program components including electronic health record modifications, outcomes reporting, and staff training were largely maintained, with nearly all (46) sites continuing to screen for tobacco use and refer patients to TUT. Perceived program partnerships were strongest with clinicians and departmental leadership, and some programs were scaled out to primary care and other specialties.

Conclusions

Results confirm that most cancer centers sustained key TUT program functions and partnerships with some increasing TUT delivery across larger cancer treatment settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tobacco Use CessationTobacco UseCancer Care FacilitiesNeoplasmsFee-for-Service PlansNational Cancer Institute (U.S.)United StatesHumansProgram EvaluationElectronic Health RecordsSurveys and Questionnaires

Stichwörter der Autor:innen

implementation sciencesustainabilitysustainmenttobacco use treatment

Autor:innen und Institutionen

  • University of Florida College of Medicine, Gainesville, Florida, USA.
  • University of Florida Health Cancer Center, Gainesville, Florida, USA.
  • University of Wisconsin Center for Tobacco Research and Intervention, Madison, Wisconsin, USA.
  • Indiana University School of Public Health, Bloomington, Indiana, USA.
  • New York University School of Global Public Health, New York, New York, USA.
  • Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Ramzi G Salloum, Magda Montague, Carma L Bylund

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Salloum, R. G., Montague, M., Minion, M., LeLaurin, J. H., Lee, J. H., Ramly, E., Liu, G., Reid, M., Bylund, C. L., McCarthy, D., Shelley, D., Ostroff, J. S., & Warren, G. W. (2025). Sustainment of Tobacco Use Treatment Programs Across National Cancer Institute–Designated Cancer Centers. Cancer Medicine, 14(22). https://doi.org/10.1002/cam4.71424

Vancouver

Salloum RG, Montague M, Minion M, LeLaurin JH, Lee JH, Ramly E, et al. Sustainment of Tobacco Use Treatment Programs Across National Cancer Institute–Designated Cancer Centers. Cancer Medicine. 2025;14(22). doi:10.1002/cam4.71424

BibTeX
@article{Salloum2025,
  author = {Salloum, Ramzi G and Montague, Magda and Minion, Mara and LeLaurin, Jennifer H and Lee, Ji-Hyun and Ramly, Edmond and Liu, Gonghao and Reid, Miranda and Bylund, Carma L and McCarthy, Danielle and Shelley, Donna and Ostroff, Jamie S and Warren, Graham W},
  title = {Sustainment of Tobacco Use Treatment Programs Across National Cancer Institute–Designated Cancer Centers},
  journal = {Cancer Medicine},
  year = {2025},
  volume = {14},
  number = {22},
  doi = {10.1002/cam4.71424}
}
Kostenlos starten →